Neurodegenerative diseases are characterized by increased levels of oxidative stress and an altered mammalian target of rapamycin (mTOR)/autophagy axis; however, the mutual relationship between these two events is controversial. Previous studies in Down's syndrome (DS) and Alzheimer's disease (AD) suggested that the accumulation of protein oxidative damage results from the increased free radical production, mainly related to metabolic alterations, mitochondrial degeneration and amyloid-β deposition, and aberrant activity of protein degradative systems.

Increased mammalian target of rapamycin signaling contributes to the accumulation of protein oxidative damage in a mouse model of down's syndrome / Tramutola, Antonella; Lanzillotta, Chiara; Arena, Andrea; Barone, Eugenio; Perluigi, Marzia; DI DOMENICO, Fabio. - In: NEURODEGENERATIVE DISEASES. - ISSN 1660-2854. - 16:1-2(2016), pp. 62-68. [10.1159/000441419]

Increased mammalian target of rapamycin signaling contributes to the accumulation of protein oxidative damage in a mouse model of down's syndrome

TRAMUTOLA, ANTONELLA;LANZILLOTTA, CHIARA;ARENA, ANDREA;BARONE, EUGENIO;PERLUIGI, Marzia;DI DOMENICO, FABIO
2016

Abstract

Neurodegenerative diseases are characterized by increased levels of oxidative stress and an altered mammalian target of rapamycin (mTOR)/autophagy axis; however, the mutual relationship between these two events is controversial. Previous studies in Down's syndrome (DS) and Alzheimer's disease (AD) suggested that the accumulation of protein oxidative damage results from the increased free radical production, mainly related to metabolic alterations, mitochondrial degeneration and amyloid-β deposition, and aberrant activity of protein degradative systems.
2016
mammalian target of rapamycin; autophagy; protein oxidation; down’s syndrome; alzheimer’s disease
01 Pubblicazione su rivista::01a Articolo in rivista
Increased mammalian target of rapamycin signaling contributes to the accumulation of protein oxidative damage in a mouse model of down's syndrome / Tramutola, Antonella; Lanzillotta, Chiara; Arena, Andrea; Barone, Eugenio; Perluigi, Marzia; DI DOMENICO, Fabio. - In: NEURODEGENERATIVE DISEASES. - ISSN 1660-2854. - 16:1-2(2016), pp. 62-68. [10.1159/000441419]
File allegati a questo prodotto
File Dimensione Formato  
Tramutola_Increased_2016

solo gestori archivio

Tipologia: Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 169 kB
Formato Adobe PDF
169 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/840612
Citazioni
  • ???jsp.display-item.citation.pmc??? 22
  • Scopus 35
  • ???jsp.display-item.citation.isi??? 34
social impact